• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性醛固酮增多症 I-III 型。

Familial hyperaldosteronism I-III.

机构信息

Department of Nephrology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

出版信息

Horm Metab Res. 2010 Jun;42(6):424-8. doi: 10.1055/s-0029-1246187. Epub 2010 Feb 3.

DOI:10.1055/s-0029-1246187
PMID:20131203
Abstract

Primary aldosteronism is the most frequent cause of secondary hypertension. Three variants of familial hyperaldosteronism are known today. Early onset hypertension and severe target organ damage are hallmarks of the heritable forms. The underlying gene defect has already been identified in familial hyperaldosteronism type I. In type II and III research is ongoing. A highly variable phenotype often precludes the discovery of the familial appearance of these syndromes. Taking a sound family history is extremely important to discover the Mendelian pattern of inheritance. The identification of affected families is highly rewarding because all variants can potentially be cured or at least specifically treated. Testing the relatives of an index patient sometimes even allows preemptive treatment. However, the availability of specific treatment options necessitates a solid differentiation between the three syndromes to avoid unnecessary medical therapy or surgery.

摘要

原发性醛固酮增多症是最常见的继发性高血压病因。目前已知三种家族性高醛固酮血症的变异型。早发高血压和严重靶器官损害是遗传性形式的特征。家族性醛固酮增多症 I 型的潜在基因缺陷已经确定。在 II 型和 III 型中,研究正在进行。高度可变的表型常常使这些综合征的家族表现难以发现。详细了解家族史对于发现孟德尔遗传模式非常重要。发现受影响的家族是非常有价值的,因为所有的变异型都有可能被治愈,或者至少可以得到特异性治疗。对索引患者的亲属进行检测有时甚至可以进行预防性治疗。然而,特定治疗方案的可用性需要在这三种综合征之间进行明确区分,以避免不必要的药物治疗或手术。

相似文献

1
Familial hyperaldosteronism I-III.家族性醛固酮增多症 I-III 型。
Horm Metab Res. 2010 Jun;42(6):424-8. doi: 10.1055/s-0029-1246187. Epub 2010 Feb 3.
2
Monogenic mineralocorticoid hypertension.单基因盐皮质激素性高血压
Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):401-20. doi: 10.1016/j.beem.2006.07.008.
3
Detecting and treating primary aldosteronism: primary aldosteronism.原发性醛固酮增多症的检测与治疗:原发性醛固酮增多症
Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):171-4. doi: 10.1055/s-2007-970409.
4
Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.意大利以及澳大利亚和南美家族中,7号染色体p22区域存在II型家族性醛固酮增多症连锁关系的进一步证据。
J Hypertens. 2008 Aug;26(8):1577-82. doi: 10.1097/HJH.0b013e3283028352.
5
Primary aldosteronism: learning from the study of familial varieties.原发性醛固酮增多症:从家族性类型的研究中学习
J Hypertens. 2000 Sep;18(9):1165-76. doi: 10.1097/00004872-200018090-00002.
6
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
7
Evaluation of primary aldosteronism.原发性醛固酮增多症的评估。
Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):188-93. doi: 10.1097/MED.0b013e3283390f8d.
8
Primary aldosteronism: an update on screening, diagnosis and treatment.原发性醛固酮增多症:筛查、诊断及治疗的最新进展
J Hypertens. 2008 Apr;26(4):613-21. doi: 10.1097/HJH.0b013e3282f4b3e6.
9
Screening for primary aldosteronism.原发性醛固酮增多症的筛查
Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):369-84. doi: 10.1016/j.beem.2006.07.007.
10
Does dynamic testing have a place in the modern assessment of endocrine hypertension?动态测试在现代内分泌高血压评估中是否有一席之地?
J Endocrinol Invest. 2003;26(7 Suppl):92-8.

引用本文的文献

1
Molecular Mechanisms of Primary Aldosteronism.原发性醛固酮增多症的分子机制。
Endocrinol Metab (Seoul). 2019 Dec;34(4):355-366. doi: 10.3803/EnM.2019.34.4.355.
2
Genetics and epigenetics of adrenocortical tumors.肾上腺皮质肿瘤的遗传学和表观遗传学。
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9.